Skip to content

Screener

Eligibility screening

A First-in-Human Single and Multiple Ascending Dose Study of MT-251

Sponsored by Mirador Therapeutics, Inc.Study detailsClinicalTrials.gov

1 US site in CA

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.